Emergency Evaluation and Management
This 39-year-old female with excruciating joint pain, high fever (39°C), and vomiting requires immediate evaluation for Adult-Onset Still's Disease (AOSD), now recognized as Still's Disease, along with urgent assessment for life-threatening complications including macrophage activation syndrome (MAS) and sepsis. 1
Immediate Diagnostic Workup
Obtain the following laboratory tests emergently:
- Complete blood count with differential - Look for leukocytosis >10,000 with >80% neutrophils (granulocytes), which is a major diagnostic criterion 2
- Inflammatory markers - ESR and CRP will be markedly elevated 2
- Serum ferritin - Expect very high levels (often 4,000-30,000 ng/ml, sometimes up to 250,000 ng/ml) 2
- Glycosylated ferritin fraction - If available, <20% is highly specific (93% specificity) for Still's Disease 2
- Liver function tests - Frequently abnormal in AOSD 2
- Rheumatoid factor and ANA - Must be negative for diagnosis 2
- Blood cultures - Essential to exclude sepsis given the clinical presentation 3
Key Clinical Features to Assess
Examine specifically for:
- Fever pattern - Quotidian or double quotidian spikes >39°C, typically peaking in late afternoon/evening, lasting <4 hours 2
- Characteristic rash - Evanescent, salmon-pink, maculopapular eruption on proximal limbs and trunk, often appearing with fever spikes 2
- Sore throat - Present in 35-92% of cases 2
- Joint involvement - Particularly assess knees, wrists, ankles for symmetric polyarthritis 2
- Lymphadenopathy and/or splenomegaly - Common findings 2
Diagnostic Criteria Application
Use the Yamaguchi criteria (most widely validated): Requires 5 criteria with at least 2 major 2:
Major criteria:
- Fever >39°C for >1 week
- Arthralgia ≥2 weeks
- Typical rash
- WBC >10,000 with >80% granulocytes
Minor criteria:
- Sore throat
- Lymphadenopathy and/or splenomegaly
- Abnormal liver function tests
- Negative RF and ANA
Critical exclusion: Must rule out infections, malignancies (particularly acute leukemia which can mimic AOSD), and other rheumatic diseases 2, 4
Emergency Management
Immediate Treatment Priorities
Based on the 2024 EULAR/PReS guidelines, early aggressive therapy is essential 1:
Glucocorticoids - 76-95% response rate; most patients require steroids at some point 2. Start high-dose prednisone (typically 0.5-1 mg/kg/day) immediately if AOSD is strongly suspected and infection excluded
IL-1 or IL-6 inhibitors - The 2024 guidelines emphasize early use of biologic therapy (IL-1 or IL-6 inhibitors) combined with short-duration glucocorticoids as optimal strategy 1
NSAIDs - Only 7-15% of patients respond to NSAID monotherapy alone; most require escalation 2. Consider indomethacin or naproxen if used 2
Critical Complication Screening
Assess urgently for Macrophage Activation Syndrome (MAS) - a life-threatening complication requiring high-dose glucocorticoids 1. Look for:
- Sudden worsening despite treatment
- Falling blood counts (especially platelets)
- Rising ferritin
- Hepatic dysfunction
- Coagulopathy
Common Pitfalls to Avoid
- Do not dismiss as simple viral syndrome - The combination of excruciating arthralgia, high fever, and vomiting warrants thorough evaluation 3
- Do not delay bone marrow examination if cytopenias are present - Acute leukemia can mimic AOSD with arthralgia, fever, rash, and thrombocytopenia 4
- Do not rely on oral temperatures - Core temperatures are more reliable if fever assessment is critical 3
- Do not wait for complete diagnostic certainty before treating - If sepsis is excluded and AOSD is likely, empiric treatment with steroids should begin promptly as 88% of patients eventually require prednisone 2
Therapeutic Target
The goal is clinically inactive disease (CID), defined as remission maintained for at least 6 months 1. This represents a paradigm shift toward early aggressive treatment rather than sequential escalation.